Application of an HPLC-MS/MS method for Teicoplanin drug substance and related impurities, part 2: identity assignment of related impurities

Publication date: Available online 13 February 2019Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Sara Tengattini, Federica Corana, Davide Bianchi, Giorgio Marrubini, Raffaella Colombo, Sandra Furlanetto, Marco Terreni, Caterina TemporiniAbstractA liquid chromatographic MS-compatible method was applied to the structural elucidation of Teicoplanin for identification CRS components. The method, previously developed by our group, involves the use of LiChrospher 100 RP-18 column with a mobile phase composed of ammonium formate 25 mM at pH 6.00 and acetonitrile (ACN).All the peaks with a 0.10% UV area, largely above the disregard limit of 0.15 % as fixed by EMA, were considered and submitted to MS/MS fragmentation experiments. The study of MS/MS spectrum collected for Teicoplanin complex major component (namely A2-2) allowed to elucidate the fragmentation pathway and enabled the successful identity assignment of all the 42 detected species. Elution order was also rationalized.An in house batch sample of Teicoplanin was analyzed and, while the 86% of the detected species were structurally identical to those in Teicoplanin for identification CRS, five new derivatives were revealed and structurally characterized.In both the Teicoplanin samples, all the considered species were found to have a Teicoplanin-like structure that allows their classification as closely related impurities, with a significant implication in their qualification threshold.
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research